Organization
Kirby Institute
8 clinical trials
Clinical trial
Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486Status: Completed, Estimated PCD: 2020-09-15
Clinical trial
Comparison of Immunity-boosting Regimens for COVID-19 Upon Initiation of Immunosuppressive TherapyStatus: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
A Phase IV Open-label Multicentre International Pilot Study of 4-week Treatment With Sofosbuvir (400 mg) Plus Glecaprevir/Pibrentasvir (300mg/120mg) in Chronic HCV Treatment naïve Patients With Early Liver DiseaseStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Strategic Therapeutic Intervention to Enhance Linkage to Care in People Who Inject DrugsStatus: Recruiting, Estimated PCD: 2025-02-12
Clinical trial
A Phase III/IV Factorial Randomized Double-blind Trial to Compare the Addition of Dapagliflozin vs Placebo and Rosuvastatin/Ezetimibe Versus Pitavastatin in Patients With HIV on Integrase Strand Transfer Inhibitor-based Antiretrovirals With Elevated Metabolic RiskStatus: Not yet recruiting, Estimated PCD: 2025-07-01
Clinical trial
Impact of the Daily Doxycycline Pre-exposure Prophylaxis (PrEP) on the Incidence of Syphilis, Gonorrhoea and ChlamydiaStatus: Active (not recruiting), Estimated PCD: 2024-07-17
Clinical trial
Body Composition Sub-study of the D2EFT TrialStatus: Active (not recruiting), Estimated PCD: 2024-01-15
Clinical trial
A Multi-centre Randomised Controlled Trial Evaluating the Efficacy of the Four-component Meningococcal B Vaccine, 4CMenB (Bexsero®), in the Prevention of Neisseria Gonorrhoeae Infection in Gay and Bisexual MenStatus: Active (not recruiting), Estimated PCD: 2024-10-01